Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1848-1853
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1848
Table 1 Baseline characteristics of persons with and without hepatic steatosis.
UnitNo teatosis n = 2 961Steatosis n = 1 261P
Ageyr47.1±16.757.2±13.3<0.001
Gender (male)1283 (43.3%)787 (62.4%)<0.001
Mean daily alcoholmg/d10.6±16.216.0±23.1<0.001
consumption
Alcohol consumption
none1060 (35.8%)415 (32.9%)<0.001
mild1331 (45.0%)477 (37.8%)
moderate258 (8.7%)129 (10.2%)
heavy294 (9.9%)234 (18.6%)
MCVmm³89.9±4.490.6±4.8<0.001
CDT%4.8±1.64.9±1.80.23
GGTmmol/L×s0.4±0.41.0±2.2<0.001
GOTmmol/L×s0.3±0.10.5±0.3<0.001
GPTmmol/L×s0.4±0.20.7±0.4<0.001
Table 2 Atherosclerotic risk factors in persons with and without hepatic steatosis.
UnitNo steatosis
Steatosis
P1(unadjusted)P2(adjusted)
n = 2961n = 1261
Smoking (current)984 (33.2%)335 (26.7%)<0.0010.75
Hemoglobin A1c%5.3±0.85.9±1.2<0.001<0.001
Diabetes mellitus134 (4.5%)240 (19.0%)<0.001<0.001
Systolic blood pressuremmHg133±21146±20<0.001<0.001
Diastolic blood pressuremmHg82±1187±11<0.001<0.001
Hypertension1274 (43.0%)945 (74.9%)<0.001<0.001
BMIkg/m²26.1±4.330.1±4.6<0.001<0.001
Overweight1657 (56.0%)1116 (88.5%)<0.001<0.001
Cholesterolmmol/L5.7±1.26.1±1.3<0.001<0.001
LDL cholesterolmmol/L3.5±1.23.8±1.2<0.0010.01
HDL cholesterolmmol/L1.5±0.41.3±0.5<0.001<0.001
Lipoprotein (a)mg/L217±283204±2800.150.06
Fibrinogeng/L2.9±0.73.1±0.7<0.0010.26
Table 3 Carotid IMT and plaques in persons with and without hepatic steatosis.
UnitNo steatosisSteatosisP
IMTmm0.784±0.1720.811±0.170<0.001
IMT, adjusted for gender and agemm0.789±0.0040.803±0.005<0.05
IMT, adjusted for the full model1mm0.813±0.0040.806±0.0050.34
PlaqueOR (CI)1.0 (Ref.)1.66 (1.38–2.00)<0.001
Plaque, adjusted for gender and ageOR (CI)1.0 (Ref.)1.60 (1.30–1.97)<0.001
Plaque, adjusted for full model1OR (CI)1.0 (Ref.)1.35 (1.03–1.61)<0.05